Concepedia

Emil Kazounis

EK

Statistics

Publications

4

Citations

489

H-Index

4

Active since

2022

Affiliations

London School of Hygiene & Tropical Medicine(Current)

Médecins Sans Frontières

Médecins Sans Frontières‎

University College London

Burnet Institute

Emil Kazounis is an author at London School of Hygiene & Tropical Medicine specializing in public health, preventive treatment, and tuberculosis prevention.

ORCID

Top concepts

Publications per year

2022–2023

4

Publications

4

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 318 citations · Full text

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · The Lancet Respiratory Medicine · 2023 · 79 citations · Full text

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis

Catherine Berry, Philipp du Cros, Katherine Fielding et al. · Trials · 2022 · 61 citations · Full text

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

Sedona Sweeney, Catherine Berry, Emil Kazounis et al. · PLOS Global Public Health · 2022 · 31 citations · Full text

, , +20

1–4 of 4